Lymph Node Flow Cytometry as a Prompt Recognition of Ultra Early Onset PTLD: A Successful Case of Rituximab Treatment

por Li, Xiaofan, Li, Nainong, Yang, Ting, Chen, Zhizhe, Hu, Jianda
Publicado 2015

Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

por XU, ZHENSHU, ZHANG, JINYAN, WU, SHUNQUAN, ZHENG, ZHIHONG, CHEN, ZHIZHE, ZHAN, RONG
Publicado 2013

Machine Learning Models for the Diagnosis and Prognosis Prediction of High-Grade B-Cell Lymphoma

por Kong, Hui, Zhu, Haojie, Zheng, Xiaoyun, Jiang, Meichen, Chen, Lushan, Lan, Lingqiong, Ren, Jinhua, Luo, Xiaofeng, Zheng, Jing, Zheng, Zhihong, Chen, Zhizhe, Hu, Jianda, Yang, Ting
Publicado 2022

A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients rec...

por Chen, Shaozhen, Lin, Kangni, Li, Qian, Luo, Xiaofeng, Xiao, Min, Chen, Minmin, Zhu, Haojie, Chen, Yongquan, Wu, Xueqiong, Zeng, Yanling, Zhang, Yuxin, Ally, Issa Hajji, Xu, Jingjing, Ren, Jinhua, Chen, Zhizhe, Hu, Jianda, Yang, Ting
Publicado 2021

Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT

por Ren, Jinhua, Lin, QiaoXian, Chen, Qi, Xu, Jingjing, Chen, Dabin, Chen, Renli, Lin, Kangni, Zhu, Haojie, Ye, Chenjing, Luo, Xiaofeng, Chen, Shaozhen, Kong, Hui, Lin, Qiong, Li, Nan, Lin, Xu, Chen, Zhizhe, Hu, Jianda, Yang, Ting
Publicado 2023

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancie...

por Yang, Ting, Lin, Qiaoxian, Ren, Jinhua, Chen, Ping, Yuan, Xiaohong, Luo, Xiaofeng, Liu, Tingbo, Zheng, Jing, Zheng, Zhihong, Zheng, Xiaoyun, Chen, Xinji, Zhang, Langhui, Zheng, Hao, Chen, Zaisheng, Hua, Xueling, Le, Shaohua, Li, Jian, Chen, Zhizhe, Hu, Jianda
Publicado 2016